Page 4 - Griefswald News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share it
Researchers in Germany, Norway and Austria have put forward a hypothesis for why in some very rare cases the coronavirus vaccine developed by AstraZeneca and the University of Oxford seems to trigger an abnormal and potentially life-threatening combination of blood clotting and low platelet counts.
The apparent side effect has been documented in a little more than 220 people among the more than 34 million vaccinated with the shot in Europe and the U.K. through April 4. On Wednesday, the European Medicines Agency confirmed a possible link to the vaccine and asked AstraZeneca to conduct more tests. The regulator reiterated the benefits of immunization outweigh the risks, noting the side effect s extreme rarity as well as the risks of COVID-19 from which the vaccine protects. ....

Mecklenburg Vorpommern , Andreas Greinacher , Emer Cooke , Peter Arlett , Thomas Thiele , University Of Griefswald , University Of Oxford , European Medicines Agency , New England Journal , மெக்லென்பர்க் வோர்பொம்மேர்ன் , எமர் சமைக்க , தாமஸ் திிேலே , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , புதியது இங்கிலாந்து இதழ் ,